Different from the previous research results, Dyskerin is low in endometrial carcinoma, and the decrease of Dyskerin expression is related to the proliferation of endometrial carcinoma and the low survival rate of patients (125). This evidence concerns the gene DKC1 and endometrial carcinoma.